Brain natriuretic peptide increases in septic patients without severe sepsis or shock

European Journal of Internal Medicine

Volumn 18, Issue 7, 2007, Pages 535-541

  Nikolaou, Nikolaos I ^a   Goritsas, Constantin ^b   Dede, Maria ^b   Paissios, Nikolaos P ^b   Papavasileiou, Michalis ^a   Rombola, Amalia T ^c   Ferti, Angeliki ^b  

^a AGIA OLGA HOSPITAL   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

^c ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Brain natriuretic peptide; Community; Infection; Sepsis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; MYOGLOBIN;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; BLOOD SAMPLING; COMMUNITY; CRITICAL ILLNESS; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTOR VARIABLE; SEPSIS; SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 35448968367     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2007.01.006     Document Type: Article

References (50)

1. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. New Engl J Med 339 (1998) 321-328
2. Struthers A.D. Plasma concentration of brain natriuretic peptides: will this new test reduce the need for cardiac investigations?. Br Heart J 70 (1993) 397-398
3. Mair J., Hammerer-Lercher A., and Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 39 (2001) 571-588
4. Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology: Remme WJ and Swedberg K (Co-Chairmen). Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22 (2001) 1527-1560
5. Talwar S., Squire I.B., Downie P.F., Davies J.E., and Ng L.L. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 84 (2000) 421-424
6. Morita E., Yasue H., Yoshimura M., Ogawa H., Jougasaki M., Matsumura T., et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88 (1993) 89-91
7. Kyriakides Z.S., Markianos M., Michalis L., Antoniadis A., Nikolaou N.I., and Kremastinos D.Th. Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty. Clin Cardiol 23 (2000) 285-288
8. Nikolaou N.I., Kyriakides Z.S., Tsaglis E.P., Antonatos D.G., Kartsagoulis D.C., and Tsigas D. Early brain natriuretic peptide increase reflects acute myocardial ischemia in patients with ongoing chest pain. Int J Cardiol 101 (2005) 223-229
9. De Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
10. Masters R.G., Davies R.A., Veinot J.P., Hendry P.J., Smith S.J., and de Bold A.J. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation 100 (1999) 287-291
11. Matsuo K., Nishikimi T., Yutani C., Kurita T., Shimizu W., Taguchi A., et al. Diagnostic value of plasma levels of brain natriuretic peptide in arrhythmogenic right ventricular dysplasia. Circulation 98 (1998) 2433-2440
12. Maron B.J., Tholakanahalli V.N., Zenovich A.G., Casey S.A., Duprez D., Aeppli D.M., et al. Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy. Circulation 109 (2004) 984-989
13. Ishikawa C., Tsutamoto T., Fujii M., Sakai H., Tanaka T., and Horie M. Prediction of mortality by high-sensitivity C-reactive protein and brain natriuretic peptide in patients with dilated cardiomyopathy. Circ J 70 (2006) 857-863
14. Nessmith M.G., Fukuta H., Brucks S., and Little W.C. Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery. Am J Cardiol 96 (2005) 1445-1448
15. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., and Burnett J.C. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40 (2002) 976-982
16. Wang F.G., Larson M.G., Levy D., Leip L.P., Benjamin E.J., Wilson P.W., et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 90 (2002) 254-258
17. Pieralli F., Olivotto I., Vanni S., Conti A., Camaiti A., Targioni G., et al. Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am J Cardiol 97 (2006) 1386-1390
18. Maeder M., Ammann P., Rickli H., and Diethelm M. Elevation of B-type natriuretic peptide levels in acute respiratory distress syndrome. Swiss Med Wkly 133 (2003) 515-518
19. Charpentier J., Luyt C.E., Fulla Y., Vinsonneau C., Cariou A., Grabar S., et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32 (2004) 660-665
20. Witthaut R., Busch C., Fraunberger P., Walli A., Seidel D., Pilz G., et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 29 (2003) 1696-1702
21. Tung R.H., Garcia C., Morss A.M., Pino R.M., Fifer M.A., Thompson B.T., et al. Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 32 (2004) 1643-1647
22. Castillo J.R., Zagler A., Carrillo-Jimenez R., and Hennekens C.H. Brain natriuretic peptide: a potential marker for mortality in septic shock. Int J Infect Dis 8 (2004) 271-274
23. Cutherson B.H., Patel R.R., Croal B.L., Barclay J., and Hillis G.S. B-type natriuretic peptide and the prediction of outcome in patients admitted to intensive care. Anaesthesia 60 (2005) 16-21
24. McLean A.S., and Huang S.J. The applications of B-type natriuretic peptide measurement in the intensive care unit. Curr Opin Crit Care 11 (2005) 406-412
25. Hatemink J.K., Groeneveld J., de Groot M.C., Struck van Schijndel R.J., van Kamp G., and Thijs L.G. Alpha-atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock. Crit Care Med 29 (2001) 80-87
26. Chua G., and Kang-Hoe L. Marked elevations in N-terminal brain natriuretic peptide levels in septic shock. Crit Care 8 (2004) R248-R250
27. Roch A., Allardet-Servent J., Michelet P., Oddoze C., Forel J.M., Barrau K., et al. NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med 33 (2005) 1001-1007
28. Hoffmann U., Brueckmann M., Bertsch T., Wiessner M., Liebetrau C., Lang S., et al. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients. Clin Lab 51 7-8 (2005) 373-379
29. Morgenthaler N.G., Struck J., Christ-Crain M., Bergmann A., and Muller B. Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHEE II score: an observational study. Crit care 9 (2005) R37-R45
30. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP /SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 (1992) 1644-1655
31. Macfarlane J., Holmes W., Gard P., Macfarlane R., Rose D., Weston V., et al. Prospective study of the incidence, etiology and outcome of adult lower respiratory tract illness in the community. Thorax 56 2 (Feb 2001) 109-114
32. Stamm W.E. Criteria for the diagnosis of urinary tract infection and for the assessment of therapeutic effectiveness. Infection 20 Suppl 3 (1992) S151-S154 (discussion S160-161)
33. Price S., Anning P.B., Mitchell J.A., and Evans T.W. Myocardial dysfunction in sepsis: mechanisms and therapeutic implications. Eur Heart J 20 (1999) 715-724
34. Muller-Werdan U., and Werdan K. Septic cardiomyopathy. Curr Opin Crit Care 5 (1999) 415-420
35. Witthaut R. Science review: Natriuretic peptides in critical illness. Crit Care 8 (2004) 342-349
36. Tomaru Ki K., Arai M., Yokoyama T., Aihara Y., Sekiguchi Ki K., Tanaka T., et al. Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes. J Mol Cell Cardiol 34 (2002) 649-659
37. Thaik C.M., Calderone A., Takahashi N., and Colucci W.S. Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest 96 (1995) 1093-1099
38. He Q., and LaPointe M.C. Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. Hypertension 33 (1999) 283-289
39. Kuwahara K., Saito Y., Harada M., Ishikawa M., Ogawa E., Miyamoto Y., et al. Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro. Circulation 100 (1999) 1116-1124
40. MacGowan G.A., Mann D.L., Kormos R.L., Feldman A.M., and Murali S. Circulating interleukin-6 in severe heart failure. Am J Cardiol 79 (1997) 1128-1131
41. Gendrel D., Raymond J., Coste J., Moulin F., Lorrot M., Guérin S., et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J 18 10 (Oct 1999) 875-881
42. Mackowiak P.A. Temperature regulation and the pathogenesis of fever. Mandell, Douglas and Bennett's. Principles and Practice of Infectious Diseases. 5th Ed. (2000), Churchill Livingstone 612-613
43. Korppi M., and Kroger L. C-reactive protein in viral and bacterial respiratory infection in children. Scand J Infect Dis 25 2 (1993) 207-213
44. Braunwald E., Colucci W.S., and Grossman W. Braunwald. Heart disease. A textbook of cardiovascular medicine. 5th Ed. (1997), W.B Saunders Co 449
45. Watts G.F., and Marwick T.H. Ventricular dysfunction in early diabetic heart disease: detection, mechanisms and significance. Clin Sci (Lond) 105 5 (2003) 537-540
46. Rudiger A., Gasser S., Fischer M., Hornemann T., von Eckardstein A., and Maggiorini M. Comparable increase of B-type natriuretic peptide levels in patients with severe sepsis, septic shock and acute heart failure. Crit Care Med 34 (2006) 2140-2144
47. Toikka P., Irjala K., Juven T., Virkki R., Mertsola J., Leinonen M., et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 19 (2000) 598-602
48. Franz A.R., Kron M., Pohlandt F., and Steinbach G. Comparison of procalcitonin with interleukin 8, C-reactive protein and differential white blood cell count for the early diagnosis of bacterial infections in newborn infants. Pediatr Infect Dis J 18 (1999) 666-671
49. Visweswaran P., and Guntupalli J. Rhabdomyolysis. Crit Care Clin 15 (1999) 415-427
50. Lane R., and Phillips M. Rhabdomyolysis. Has many causes, including statins, and may be fatal. BMJ 327 (2003) 115-116